InvestorsHub Logo
Followers 1
Posts 95
Boards Moderated 0
Alias Born 04/05/2013

Re: TEFFY post# 1487

Sunday, 09/28/2014 1:51:58 PM

Sunday, September 28, 2014 1:51:58 PM

Post# of 18220
I don't really pay much attention to charts. I've done my DD and invested in TNIB because they've started phase 2 and phase 3 clinical trials for Crohn's, MS, pancreatic cancer and other diseases. I think LDN will have somewhat of a cruise thru phase 2 and 3 studies because it's safety isn't an issue because the 50mg dosage is already approved for drug overdose. They hired Graham Burton, formally from Celgene, as CEO. Just the fact that he signed onto CYTOCOM tells me he believes in LDN and the other drugs in the TNIB arsenal. He's a smart man and wouldn't give up a job that paid millions. The spin out company, CYTOCOM under Graham Burton and the 1 for 1 share of TNIB and Cytocom. Robert Gallo and Robert Redfield who discovered HIV are part of the scientific team. These are perhaps the biggest names in AIDS research. The sale of LDN in Africa. Also in the bio drug world companies can sell for billions in the course of a few weeks, sometimes days. Also if you look at MS websites people have written about how much they've been helped by LDN. Actually when I look at the charts I see that it's a great time to buy more shares because I think it's a bargain at .30 a share. I think at this time next year, maybe sooner, the people who have faith in this company will be rewarded big time.